Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141619 |
| CAS No | NA |
| Mol.F. | C22H18ClN3O6 |
| Mol.Wt. | 455.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141620 |
| CAS No | NA |
| Mol.F. | C16H17FN4O3 |
| Mol.Wt. | 332.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141621 |
| CAS No | NA |
| Mol.F. | C16H18FN3O3S |
| Mol.Wt. | 351.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141622 |
| CAS No | NA |
| Mol.F. | C21H25FN4O7S |
| Mol.Wt. | 496.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141623 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141624 |
| CAS No | NA |
| Mol.F. | C26H38N4O7 |
| Mol.Wt. | 518.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141625 |
| CAS No | NA |
| Mol.F. | C26H38N4O7 |
| Mol.Wt. | 518.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141626 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141627 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141628 |
| CAS No | NA |
| Mol.F. | C13H20N2O3 |
| Mol.Wt. | 252.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141629 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141630 |
| CAS No | NA |
| Mol.F. | C26H39N3O6 |
| Mol.Wt. | 489.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141631 |
| CAS No | NA |
| Mol.F. | C13H20N2O2 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141632 |
| CAS No | NA |
| Mol.F. | C20H26N2O4 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141633 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O4 |
| Mol.Wt. | 300.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141634 |
| CAS No | NA |
| Mol.F. | C13H19ClN2O4 |
| Mol.Wt. | 302.8 |
| INV STATUS | CUSTOM SYNTHESIS |